Company Profile

Pan Genome Systems LLC
Profile last edited on: 10/3/2017      CAGE: 6HD32      UEI: JL8AEENHA1Q6

Business Identifier: Animal health vaccines & diagnostics for controlling and monitoring infectious diseases in dairy producing animals
Year Founded
2011
First Award
2012
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

505 South Rosa Road Suite 20b
Madison, WI 53719
   (608) 441-2834
   info@pangenosys.com
   www.pangenosys.com
Location: Single
Congr. District: 02
County: Dane

Public Profile

Pan Genome Systems LLC utilizes proprietary genomic information to develop better molecular diagnostics and vaccines targeting both human and animal diseases. The Company's innovations target bacterial infectious diseases causing tuberculosis, Crohn’s disease in humans as well as Johne’s disease in animals (cattle, sheep, goats, camels). Pan Genome Systems' products are available to farmers, technicians, veterinarians and veterinary labs; this is built on the discovery of proprietary genetic biomarkers and vaccine constructs. These biomarkers and constructs are unique to mycobacteria avium paratuberculosis, the bacteria that causes Johne's Disease. Pan Genome Systems' proprietary biomarkers and techniques provide the targets and methods necessary to alter specific genetic characteristics of the bacteria. This allows Pan Genome Systems' vaccines to solicit a strong and robust immune response, and sustained bacterial immunity in the host animal, while simultaneously preserving the health of the animal by eliminating bacterial virulence. The company's proprietary technology platform is paving the way for a revolution in vaccines and animal health.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 USDA $99,979
Project Title: Multivalent vaccines against Infectious Bronchitis Virus (IBV)
2016 1 USDA $99,846
Project Title: Potent Vaccine Formulas for Johne`s Disease
2013 2 USDA $549,402
Project Title: Novel Vaccines for Johne's Disease
2013 2 USDA $549,402
Project Title: Novel Vaccines for Johne's Disease

Key People / Management

  Jon Sandbrook -- President

  Justin J Lemke

  Yashdeep Phanse

  Erik Settles -- Senior Scientist

  Adel Talaat -- Chairman; Chief Executive Officer

Company News

There are no news available.